Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-21-000251
Filing Date
2021-02-01
Accepted
2021-02-01 16:43:51
Documents
90
Period of Report
2020-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bmmj_10q.htm 10-Q 667866
2 EX-3.1 bmmj_ex31.htm EX-3.1 148154
3 EX-10.1 bmmj_ex101.htm EX-10.1 89194
4 EX-10.2 bmmj_ex102.htm EX-10.2 89852
5 EX-10.3 bmmj_ex103.htm EX-10.3 71650
6 CERTIFICATION bmmj_ex311.htm EX-31.1 11175
7 CERTIFICATION bmmj_ex312.htm EX-31.2 10385
8 CERTIFICATION bmmj_ex321.htm EX-32.1 4324
  Complete submission text file 0001640334-21-000251.txt   6336890

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT bmmj-20201031.xml EX-101.INS 996984
10 XBRL TAXONOMY EXTENSION SCHEMA bmmj-20201031.xsd EX-101.SCH 133185
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmmj-20201031_cal.xml EX-101.CAL 58806
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmmj-20201031_def.xml EX-101.DEF 280454
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmmj-20201031_lab.xml EX-101.LAB 942642
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmmj-20201031_pre.xml EX-101.PRE 440110
Mailing Address 750 - 1095 WEST PENDER STREET VANCOUVER A1 V6E 2M6
Business Address 750 - 1095 WEST PENDER STREET VANCOUVER A1 V6E 2M6 604-376-3567
BODY & MIND INC. (Filer) CIK: 0001715611 (see all company filings)

EIN.: 981319227 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-55940 | Film No.: 21577288
SIC: 2834 Pharmaceutical Preparations